rs876657823
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_032119.4(ADGRV1):c.1799A>G(p.Asn600Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000342 in 1,460,922 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.1799A>G | p.Asn600Ser | missense_variant | Exon 9 of 90 | 1 | NM_032119.4 | ENSP00000384582.2 | ||
ADGRV1 | ENST00000504142.2 | n.565A>G | non_coding_transcript_exon_variant | Exon 3 of 14 | 5 | |||||
ADGRV1 | ENST00000640109.1 | n.1895A>G | non_coding_transcript_exon_variant | Exon 9 of 9 | 5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000805 AC: 2AN: 248426 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460922Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726766 show subpopulations
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Asn600Ser var iant in GPR98 has not been previously reported in individuals with hearing loss and was absent from large population studies. The asparagine (Asn) at position 6 00 is not conserved in mammals or evolutionary distant species, with Brush-taile d rat and two bird species having a serine (Ser), raising the possibility that a change at this position may be tolerated. Additional computational prediction t ools do not provide strong support for or against an impact to the protein. In s ummary, while the clinical significance of the Asn600Ser variant is uncertain, t he conservation data suggest that it is more likely to be benign. -
Inborn genetic diseases Uncertain:1
The c.1799A>G (p.N600S) alteration is located in exon 9 (coding exon 9) of the ADGRV1 gene. This alteration results from a A to G substitution at nucleotide position 1799, causing the asparagine (N) at amino acid position 600 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
ADGRV1-related disorder Uncertain:1
The ADGRV1 c.1799A>G variant is predicted to result in the amino acid substitution p.Asn600Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-89925316-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at